hypoxemia
Conditions
Interventions
Experimental group:The patient is in the supine position, and the acupoints are disinfected. A Korean acupoint stimulator (HANS 200A) is used with self-adhesive patches applied to bilateral Zusanli (S
Control group:All patients are positioned in the supine position, and the acupoints are routinely disinfected. Self-adhesive patches are applied to bilateral Zusanli (ST36) and Lieque (LU7) without el
Sponsors
Shanghai University of Traditional Chinese Medicine Affiliated Putuo Hospital
Eligibility
Sex/Gender
All
Age
60 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Patients with non-malignant digestive system diseases assessed by a clinician as meeting the SAGES (Society of American Gastrointestinal and Endoscopic Surgeons) guidelines for laparoscopic surgery; (2) Age =60 years and =90 years regardless of gender; (3) American Society of Anesthesiologists (ASA) preoperative physical status classification of I–III: Grade I: Physically healthy well-nourished with normal organ function; Grade II: Mild comorbidities in addition to the surgical condition with full functional compensation; Grade III: Severe comorbidities with limited physical activity but still capable of managing daily activities; (4) Willing to participate in the clinical trial and have signed a written informed consent form. Only those meeting all the above criteria are eligible for inclusion.
Exclusion criteria
Exclusion criteria: (1) Patients requiring concurrent other surgeries or conversion to open surgery; (2) Patients aged 90 years; (3) Patients who have participated in other clinical trials within the past month; (4) Patients with a history of allergic reactions to the planned medications; (5) Pregnant or breastfeeding women; (6) Patients with a body mass index (BMI) =35 kg/m²; (7) Patients with a history of lung surgery, pneumothorax, pulmonary tuberculosis, pleural effusion, anticipated difficult intubation, respiratory failure, or severe pulmonary dysfunction unsuitable for the current anesthesia protocol; (8) Patients with severe cardiac conduction block (second- or third-degree atrioventricular block, bifascicular block), severe sinus node dysfunction, congestive heart failure, or implanted cardiac pacemakers; (9) Patients with anatomical abnormalities or skin diseases near the site of transcutaneous acupoint electrical stimulation. Meeting any one of the above criteria warrants exclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative Blood Oxygen and Postoperative Discomfort VAS Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital stay: the duration from the end of the surgery to discharge;Other qualitative patient indicators;Number of airway rescue interventions (defined as the need for non-invasive positive pressure ventilation with a mask or re-intubation);Vital signs at six time points: blood pressure heart rate (T0: start of surgery T1: extubation at the end of surgery T2: 1 hour after TEAS procedure T3-T5: every 8 hours for 3 measurements after returning to the ward);Postoperative complications: other postoperative complications will be recorded in the CRF (Case Report Form);Intraoperative opioid dosage;Length of stay in the PACU (Post Anesthesia Care Unit);Postoperative blood gas analysis results; | — |
Countries
China
Contacts
Public ContactLongkai Sun
Shanghai University of Traditional Chinese Medicine Affiliated Putuo Hospital
Outcome results
None listed